Elanco Animal Health Incorporated (ELAN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Elanco Animal Health Incorporated (ELAN) is up 4.4% since the beginning of the year. At $24 per share, ELAN is trading 14.8% below its 52-week high of $28. Investors who bought $1,000 worth of ELAN shares 5 years ago would now be looking at an investment worth $675.

Elanco Animal Health Incorporated (ELAN) has returned 4.42% so far this year and 76.08% over the past 12 months.

Based on dividend-adjusted daily data since Sep 20, 2018, ELAN's average daily return is +0.02%, while the average monthly return is +0.35%. At this rate, an investment would double in approximately 16.5 years.

Historically, 47% of months were positive and 53% were negative. The best month was May 2025 with a return of +41.8%, while the worst month was Aug 2022 at -25.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.

On a daily basis, ELAN closed higher 48% of trading days. The best single day was May 7, 2025 with a return of +26.3%, while the worst single day was Jun 27, 2024 at -20.6%.

Elanco Animal Health Incorporated has an annualized alpha of -10.79%, beta of 1.08, and R2 of 0.23 versus S&P 500 Index. Calculated based on daily prices since September 21, 2018.

• This stock participated in 160.83% of S&P 500 Index downside but only 104.73% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.23 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ELAN ranks 83 for risk / return — in the top 83% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Elanco Animal Health Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Elanco Animal Health Incorporated was 78.00%, occurring on May 30, 2023. The portfolio has not yet recovered.

The current Elanco Animal Health Incorporated drawdown is 35.65%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Elanco Animal Health Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Elanco Animal Health Incorporated is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.